Inhibition of H 2 S Production Reduces Portal Pressure and Attenuates Liver Fibrosis in Bile Duct-Ligated Rats
Journal of Vascular Research · 18.05.2026 · 1-11
DOI: 10.1159/000552592 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Research, online erschienen am 18.05.2026. Verfasst von Raffaele Buono und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinica Medica 5, Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine - DIMED, University of Padova, Padova, Italy. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hydrogen sulfide (H2S) is a gaseous signalling molecule with vasodilatory properties and regulates inflammation and fibrosis in the liver.
Methods
Rats with bile duct ligation (BDL)-induced liver disease were treated with propargylglycine (PAG; 30 mg/kg via intragastric gavage), a selective inhibitor of cystathionine γ-lyase, the main source of H2S in the cardiovascular system and liver, or vehicle. PAG treatment was initiated at day 5 after BDL to evaluate its effects on the progression of liver fibrosis and portal hypertension.
Results
In BDL rats, PAG significantly reduced portal pressure (PP) (10.4 ± 2.7 mm Hg versus 16.0 ± 3.9 mm Hg, p < 0.05) without affecting systemic pressure. In mesenteric arteries mounted on a wire myograph, no differences were observed in responses to acetylcholine and H2S donor sodium hydrosulfide between treated and untreated BDL rats. In the liver, PAG treatment significantly reduced the expression of IL-6, TGF-β, and collagen I and markedly attenuated hepatic fibrosis and architectural distortion. Rats treated with PAG also exhibited significantly lower alanine aminotransferase.
Conclusion
In BDL rats, inhibition of H2S synthesis decreases PP and attenuates liver fibrosis, suggesting that targeting H2S may represent a therapeutic strategy for portal hypertension, potentially through modulation of intrahepatic resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinica Medica 5, Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine - DIMED, University of Padova, Padova, Italy.
- Laboratory Medicine Unit, AULSS8 Berica, Vicenza, Italy.
- Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
- Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy.
- Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.
- Clinica Medica 5, Unit of Internal Medicine and Hepatology (UIMH), Department of Medicine - DIMED, University of Padova, Padova, Italy, marco.dipascoli@unipd.it.
Zitieren
APA
Buono, R., Crescenzi, M., Brocca, A., Dedja, A., Gasparello, J., Fassan, M., Bolognesi, M., & Di Pascoli, M. (2026). Inhibition of H 2 S Production Reduces Portal Pressure and Attenuates Liver Fibrosis in Bile Duct-Ligated Rats. Journal of Vascular Research, 1-11. https://doi.org/10.1159/000552592
Vancouver
Buono R, Crescenzi M, Brocca A, Dedja A, Gasparello J, Fassan M, et al. Inhibition of H 2 S Production Reduces Portal Pressure and Attenuates Liver Fibrosis in Bile Duct-Ligated Rats. Journal of Vascular Research. 2026:1-11. doi:10.1159/000552592
BibTeX
@article{Buono2026,
author = {Buono, Raffaele and Crescenzi, Marika and Brocca, Alessandra and Dedja, Arben and Gasparello, Jessica and Fassan, Matteo and Bolognesi, Massimo and Di Pascoli, Marco},
title = {Inhibition of H 2 S Production Reduces Portal Pressure and Attenuates Liver Fibrosis in Bile Duct-Ligated Rats},
journal = {Journal of Vascular Research},
year = {2026},
pages = {1--11},
doi = {10.1159/000552592}
}
EUVIMED